Genetic variants increase risk for H. pylori-related stomach cancer

Individuals with certain germline pathogenic variants had a substantially higher risk for developing gastric cancer after Helicobacter pylori infection, results of a Japan-based case-control study showed.The findings, published in The New England Journal of Medicine, suggest risk for gastric cancer is more heavily related to hereditary factors than previously thought, the investigators noted.Four of the…

Olamkicept induces clinical response in nearly 60% of patients with active UC

Biweekly infusions of olamkicept 600 mg increased the likelihood of clinical response and mucosal healing at 12 weeks in patients with active ulcerative colitis compared with placebo, according to results published in JAMA.“Olamkicept, a first-in-class, selective inhibitor of the s-interleukin-6R/IL-6 complex, is a dimer formed by fusing two complete extracellular domains of gp130 to human…

Atopic, allergic comorbidities prevalent among patients with eosinophilic esophagitis

SAN ANTONIO — A high proportion of patients with eosinophilic esophagitis also had simultaneous atopic or allergic comorbid conditions, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.Eosinophilic esophagitis (EoE) is a chronic, progressive type II inflammatory disease, Marc E. Rothenberg, MD, PhD, director of the Cincinnati Center for…

Contact X-ray brachytherapy boost bolsters 3-year organ preservation rate in rectal cancer

Chemoradiotherapy with a contact X-ray brachytherapy boost significantly increased clinical complete response and 3-year organ preservation rates in patients with early cT2-cT3 rectal adenocarcinoma, particularly tumors smaller than 3 cm.“The standard of care for rectal cT2 to cT3 adenocarcinoma is radical proctectomy by total mesorectal excision, sometimes preceded by neoadjuvant chemoradiotherapy, external beam radiotherapy or…